Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab-Reference-Cited by-同舟云学术

Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab

Published:2015-08 Issue: Volume:62 Page:22-30
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Mahévas Matthieu,Michel Marc,Vingert Benoit,Moroch Julien,Boutboul David,Audia Sylvain,Cagnard Nicolas,Ripa Julie,Menard Cédric,Tarte Karin,Mégret Jérôme,Le Gallou Simon,Patin Pauline,Thai Lan,Galicier Lionel,Bonnotte Bernard,Godeau Bertrand,Noizat-Pirenne France,Weill Jean-Claude,Reynaud Claude-Agnès

Funder

Ligue Nationale contre le Cancer

Fondation Princesse Grace

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Competence and competition: the challenge of becoming a long-lived plasma cell;Radbruch;Nat. Rev. Immunol.,2006

2. Humoral immunity due to long-lived plasma cells;Slifka;Immunity,1998

3. Maintenance of the plasma cell pool is independent of memory B cells;Ahuja;Proc. Natl. Acad. Sci. U. S. A.,2008

4. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice;Hoyer;J. Exp. Med.,2004

5. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells;Mahevas;J. Clin. Invest.,2013

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

2. Autoimmune Hemolytic Anemias: Challenges in Diagnosis and Therapy;Transfusion Medicine and Hemotherapy;2024-08-27

3. Anti-B-Cell-Activating Factor (BAFF) Therapy: A Novel Addition to Autoimmune Disease Management and Potential for Immunomodulatory Therapy in Warm Autoimmune Hemolytic Anemia;Biomedicines;2024-07-18

4. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease;Blood Advances;2024-05-29

5. Efficacy and Safety of Weekly Bortezomib-dexamethasone as the Third-Line Therapy for Warm Autoimmune Hemolytic Anemia: a Case Series of 5 Patients;Indian Journal of Hematology and Blood Transfusion;2024-04-19